Compositions containing polymers, polymers, and uses thereof

JP2024543865AInactive Publication Date: 2024-11-26BASF SE
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2024529761
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-11-22
Filing Date
2022-11-10
Publication Date
2024-11-26
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 2024543865000001_ABST
    Figure 2024543865000001_ABST
Patent Text Reader

Abstract

A composition comprising: (A) an average molecular weight M of at least 1,500 g; w At least one polymer having the general formula (I) 1 are the same or different and are selected from hydrogen and methyl; R 1 are the same or different and are unsubstituted C2-C4-alkyl or hydroxy or -NR 2a R 2b C2-C4-alkyl substituted with R 2a and R 2b are the same or different and are selected from C1-C4-alkyl, or NR 2a R 2b together form a C5-C6-cycloalkyleneamino or 1-imidazole group, n is selected from 3 to 100, X 1 is O and NR 3 (R 3 is selected from hydrogen and methyl; 1 are the same or different, C2-C6-alkylene and (AO) y1 (wherein AO is selected from ethylene oxide, propylene oxide, and a combination thereof, and y1 is 2 to 200) as a repeating unit; and (B) at least one anionic surfactant. [Formula 1] TIFF2024543865000020.tif34170
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention provides a composition comprising: (A) an average molecular weight M of at least 1,500 g / mol; w At least one polymer having the general formula (I) [ka] [In the formula, Z 1 are the same or different and are selected from hydrogen and methyl; R 1 are the same or different and are unsubstituted C2-C4-alkyl or hydroxy or -NR 2a R 2b C2-C4-alkyl substituted with R 2a and R 2b are the same or different and are selected from C1-C4-alkyl, or NR 2a R 2b together form a C5-C6-cycloalkyleneamino or 1-imidazole group, n is selected from 3 to 100; X 1 is O and NR 3 (R 3 is selected from hydrogen and methyl; A 1 are the same or different, C2-C6-alkylene and (AO) y1 (AO is selected from ethylene oxide, propylene oxide, and combinations thereof, and y1 is selected from 2 to 200). At least one polymer containing as a repeating unit a structural unit according to (B) at least one anionic surfactant; The present invention relates to a composition comprising:

[0002] Furthermore, the present invention describes a polymer (A) and a process for producing such a polymer (A). [Background technology]

[0003] Laundry detergents must meet several requirements. They must remove all kinds of soils from laundry, including all kinds of pigments, clays, fatty soils, and dyes from foods and beverages, such as red wine, tea, coffee, and fruits, including berry juice. They must also exhibit certain storage stability. In particular, liquid laundry detergents or laundry detergents that contain hygroscopic ingredients often lack good storage stability, for example enzymes are easily deactivated.

[0004] Grease stains remain a challenge in laundry. Numerous proposals have been made for their removal, including polymers, enzymes, and surfactants, but a solution that works remains intriguing. It has been proposed to use lipases to assist in grease removal, but many builders do not work well with lipases, especially in liquid laundry detergents.

[0005] In addition, graying of laundry remains a significant problem. This graying is believed to be due to redeposition of dirt during washing. To reduce redeposition of dirt, certain natural or modified polysaccharides have been developed, such as polysaccharides treated with gaseous or liquid SO2. Numerous ingredients with different structures have been proposed (e.g. (see WO 2015 / 091160, EP 3 266 858 A1 and EP 3 226 858 A1), but there is still room for improvement and the anti-greying performance of such compounds remains unsatisfactory. Thus, there is a continuing need for improved anti-greying agents that can be used in the laundry process. In particular, it is desirable to provide anti-greying agents that reduce greying of washed fabrics. Summary of the Invention [Means for solving the problem]

[0006] It was therefore an object to provide a detergent composition that meets the requirements discussed above. It was a further object to provide ingredients that meet the above requirements, and to provide processes for producing such ingredients and detergent compositions.

[0007] Thereby, a composition as defined at the outset is found, hereinafter also referred to as the composition of the invention or the composition according to the invention, which comprises at least one polymer (A) having an average molecular weight Mw of at least 1,500 g / mol, which polymer (A) comprises specific repeating units: [ka] [In the formula, Z 1 are different or preferably identical and are selected from hydrogen and methyl; 1 It is preferred that are the same and are hydrogen. R 1 are the same or different and are C2-C4-alkyl, such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl or tert-butyl, preferably unsubstituted CH3 or C2H5 or hydroxy or -NR 2a R 2b or C2H5 substituted with R 2a and R 2b are different or preferably identical and are selected from C1-C4-alkyl, C1-C4-alkyl being as defined above, or NR 2a R 2b together form a C5-C6-cycloalkyleneamino or 1-imidazole group. 2a R 2b Preferred examples are -N(CH3)2, -N(C2H5)2, -N(CH2)4, and -N(CH2)5. Includes.

[0008] The variable n is selected from 3 to 100, preferably 3 to 45.

[0009] The repeat units are linked to one another via an asterisk *, which symbolizes a bond to another repeat unit or to an end capping group, for example according to general formula (II).

[0010] X 1 is O and NR 3 Selected from R 3 is selected from hydrogen and methyl, and all X 1 is preferably oxygen.

[0011] A 1 are the same or different and are selected from C2-C6-alkylene, for example, -(CH2)2-, -(CH2)3-, -(CH2)4-, -(CH2)5-, -(CH2)6-, preferably (AO) y1 (wherein AO is selected from ethylene oxide ("EO"), propylene oxide ("PO"), and combinations thereof, and y1 is selected from 2 to 200, preferably 2 to 10).

[0012] (AO) y1 In the embodiment where refers to a combination of EO and PO, such EO and PO may be arranged randomly or, preferably, blockwise, in two or three blocks. (AO) y1 In a preferred embodiment in which AO refers to a combination of EO and PO, at least 50 mol %, for example 50 to 90 mol %, more preferably 65 to 90 mol % of AO is EO.

[0013] Even more preferably, (AO) y1 In other words, A 1 All AOs in are EOs. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0014] In one embodiment of the present invention, the average molecular weight Mw of the polymer (A) is at least 1,500 g / mol, preferably in the range of 2,500 to 100,000 g / mol. The average molecular weight can be determined by gel permeation chromatography ("GPC") in 0.1 M aqueous NaCl solution containing 0.1% by weight of trifluoroacid as the mobile phase, or in hexafluoroisopropanol ("HFIP"), each time preferably using TSKgel as the stationary phase.

[0015] In one embodiment of the present invention, the polydispersity Q=Mw / Mn of the polymer (A) is in the range of 2-10, preferably 2.5-6.

[0016] In one embodiment of the present invention, the polymer (A) has a Hazen color number in the range of 20 to 500, measured in a 10% by weight aqueous solution.

[0017] In one embodiment of the present invention, polymer (A) has an OH value, measured according to DIN 53240 (2013), in the range of 1 to 1000, preferably 5 to 350 mg KOH / g polymer (A).

[0018] In one embodiment of the present invention, the polymer (A) is represented by the general formula (II) [ka] per molecule, preferably up to two groups.

[0019] In formula (II), A 2 (AO) y2 wherein AO is selected from ethylene oxide and propylene oxide and combinations thereof, and y2 is 2 to 200, preferably 2 to 45; Z 2 teeth, hydrogen, C1~C 10an alkyl group, such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, iso-amyl, n-hexyl, isohexyl, n-heptyl, isoheptyl, n-octyl, n-nonyl or n-decyl, preferably CH3 or C2H5, Aliphatic C2~C 20 -alkyl fatty acids, such as carboxylates of capric acid, lauric acid, myristic acid, palmitic acid, stearic acid, or arachidic acid; or C 10 ~C 20 Carboxylates of alkenyl fatty acids, such as oleic acid, palmitoleic acid, linoleic acid, linoelaidic acid, and α-linolenic acid, preferably oleic acid, lauric acid, palmitic acid, and stearic acid. is selected from.

[0020] A 2 are the same or different, (AO) y2 (wherein AO is selected from ethylene oxide ("EO") and propylene oxide ("PO"), and combinations thereof, and y2 is selected from 2 to 200, preferably 2 to 45).

[0021] (AO) y2 In the embodiment where AO refers to a combination of EO and PO, such EO and PO are arranged randomly or, preferably, blockwise, in two or three blocks. y2 In a preferred embodiment in which AO refers to a combination of EO and PO, at least 50 mol %, for example 50 to 90 mol %, more preferably 65 to 90 mol % of AO is EO.

[0022] Even more preferably, (AO) y2 In other words, A 2 All AOs in are EOs.

[0023] Preferably, A 1 and A 2 are identical.

[0024] In formula (II), the asterisk indicates the moiety attached to the N atom of polymer (A).

[0025] In one embodiment of the present invention, polymer (A) has at least one group of general formula (III) per molecule. [ka]

[0026] R 2a and R 2b are different or preferably identical and are selected from C1-C4-alkyl, C1-C4-alkyl being as defined above, or NR 2a R 2b together form a C5-C6-cycloalkyleneamino or 1-imidazole group. 2a R 2b Preferred examples are 1-imidazole, -N(CH3)2, -N(C2H5)2, -N(CH2)4, and -N(CH2)5.

[0027] The other variables are defined as above.

[0028] In one embodiment of the present invention, polymer (A) has one or two groups of general formula (III) per molecule. The groups according to general formula (III) are connected to the remainder of polymer (A) by Z 1 Bind via.

[0029] The formulation of the invention may contain from 0.1 to 10% by weight of polymer (A).

[0030] The composition of the present invention comprises (B) At least one anionic surfactant (hereinafter also referred to as anionic surfactant (B)).

[0031] Examples of anionic surfactants (B) include C8 to C 18 -Alkyl sulfate, C8~C 18-Ethoxylated C4-C fatty alcohol polyether sulfates 12 - Sulfuric acid half ester of alkylphenol (ethoxylation degree: 1 to 50 mol / mol ethylene oxide), C 12 ~C 18 Alkali metal and ammonium salts of sulfofatty acid alkyl esters, e.g. C 12 ~C 18 Sulfo fatty acid methyl esters, and further C 12 ~C 18 -Alkyl sulfonic acid and C 10 ~C 18 - the alkali metal and ammonium salts of alkylarylsulfonic acids. The alkali metal salts of the abovementioned compounds are preferred, and the sodium salts are particularly preferred.

[0032] Further examples of anionic surfactants (B) are soaps, such as the sodium or potassium salts of stearic acid, oleic acid, palmitic acid, ether carboxylates, and alkyl ether phosphates.

[0033] In a preferred embodiment of the present invention, the anionic surfactant (B) is represented by the general formula (IV) R 2 -O(CH2CH2O) x1 -SO3M (IV) [In the formula, R 2 is especially for nC with an even number of carbon atoms 10 ~C 18 -alkyl, such as n-decyl, n-dodecyl, n-tetradecyl, n-hexadecyl, or n-octadecyl, preferably C 10 ~C 14 -alkyl, and even more preferably nC 12 -alkyl, x1 is a number ranging from 1 to 5, preferably 2 to 4, and even more preferably 3; M is selected from alkali metals, preferably potassium, even more preferably sodium. The compound is selected from the compounds according to the formula:

[0034] In the anionic surfactant (B), n is not necessarily an integer, since x1 may be an average number, but in the individual molecules according to formula (IIIa), x represents an integer.

[0035] In one embodiment of the present invention, the composition of the present invention may contain 0.1 to 60% by weight, preferably 5 to 50% by weight, of an anionic surfactant (B).

[0036] The composition of the present invention may also contain impurities resulting from the synthesis of polymer (A), such as unreacted mono- or di-acids of polyalkylene oxides in which at least 50 mol % of the alkylene oxide groups are ethylene oxide groups, and polyesters based on mono-acids of polyalkylene oxides in which at least 50 mol % of the alkylene oxide groups are ethylene oxide groups.

[0037] In one embodiment of the present invention, the composition of the present invention comprises at least one enzyme. The enzyme is identified by its polypeptide sequence (also referred to herein as amino acid sequence). The sequence of the polypeptide specifies the three-dimensional structure of the enzyme, including the "active site", which in turn determines the catalytic activity of the enzyme. The polypeptide sequence can be identified by the SEQ ID NO sequence number. According to the World Intellectual Property Office (WIPO) Standard ST.25 (1998), amino acids are represented herein by three-letter code, with the first letter capitalized or the corresponding single letter.

[0038] Any enzyme according to the invention relates to a parent enzyme and / or a variant enzyme, both of which have enzymatic activity. An enzyme with enzymatic activity is enzymatically active or performs an enzymatic conversion, meaning that the enzyme acts on a substrate and converts it into a product. In this specification, the term "enzyme" excludes inactive variants of the enzyme.

[0039] A "parent" sequence (of a parent protein or enzyme, also called a "parent enzyme") is a starting sequence for the introduction of sequence changes (e.g., by introducing one or more amino acid substitutions, insertions, deletions or a combination thereof) that result in a "variant" of the parent sequence. The term parent enzyme (or parent sequence) includes wild-type enzymes (sequences) and synthetically produced sequences (enzymes) that are used as starting sequences for introducing (further) changes.

[0040] The term "enzyme variant" or "sequence variant" or "variant enzyme" refers to an enzyme that differs to some extent in its amino acid sequence from its parent enzyme. Unless otherwise specified, a variant enzyme that is "enzymatically active" means that the variant enzyme has the same type of enzymatic activity as the respective parent enzyme.

[0041] In describing variants of the present invention, the following nomenclature is used: Amino acid substitutions are described by giving the original amino acid of the parent enzyme followed by the number of the position in the amino acid sequence followed by the replaced amino acid. Amino acid deletions are described by giving the original amino acid of the parent enzyme followed by the number of the position in the amino acid sequence followed by a *. Amino acid insertions are described by giving the original amino acid of the parent enzyme followed by the number of the position in the amino acid sequence followed by the original amino acid and the additional amino acid. For example, the insertion of a lysine at position 180 next to a glycine is designated as "Gly180GlyLys" or "G180GK". If a substitution and an insertion are in the same position, this can be indicated as S99SD+S99A or in short S99AD. Degeneracy in nomenclature occurs when an amino acid residue identical to an existing amino acid residue is inserted. For example, if a glycine is inserted after the glycine in the above example, this would be indicated by G180GG. When different alterations can be introduced at a position, the different alterations are separated by commas, for example, "Arg170Tyr,Glu" represents the substitution of arginine at position 170 with tyrosine or glutamic acid, respectively. Alternatively, the different alterations or optional substitutions may be indicated in parentheses, for example, Arg170[Tyr,Gly] or Arg170{Tyr,Gly}; or simply R170[Y,G] or R170{Y,G}; or fully R170Y, R170G.

[0042] Enzyme variants can be defined by their sequence identity when compared to the parent enzyme. Sequence identity is usually indicated as "% sequence identity" or "% identity". For calculating sequence identity, in the first step, a sequence alignment needs to be generated. According to the present invention, a pairwise global alignment needs to be generated, which means that two sequences need to be aligned over their entire length, and is usually generated using a mathematical method called an alignment algorithm. According to the present invention, the alignment is generated by using the Needleman and Wunsch algorithm (J. Mol. Biol. (1979) 48, p. 443-453). Preferably, the program "NEEDLE" (European Molecular Biology Open Software Suite (EMBOSS)) is used in the present invention with the program default parameters (gap open = 10.0, gap extension = 0.5 and matrix = EBLOSUM62).

[0043] According to the present invention, the following %-identity calculations apply: %-identity=(identical residues / length of the alignment region showing the respective sequences of the present invention over their entire length)*100.

[0044] According to the present invention, an enzyme variant can be described as an amino acid sequence that is at least n% identical to the amino acid sequence of the respective parent enzyme, where "n" is an integer between 10 and 100. In one embodiment, the variant enzyme is at least 70%, at least 75%, at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% identical when compared to the full length amino acid sequence of the parent enzyme, and the enzyme variant has enzymatic activity.

[0045] "Enzyme activity" refers to the catalytic effect exerted by an enzyme and is usually expressed in units per milligram of enzyme (specific activity) related to the molecules of substrate converted per minute per molecule of enzyme (molecular activity). A variant enzyme may have an enzymatic activity according to the invention if said enzyme variant exhibits at least 20%, at least 25%, at least 30%, at least 35%, at least 40%, at least 45%, at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, or 100% of the enzymatic activity of the respective parent enzyme.

[0046] In one embodiment, the enzyme is selected from hydrolases, preferably from proteases, amylases, lipases, cellulases, mannanases.

[0047] In one embodiment of the present invention, the composition of the present invention comprises: (C) at least one hydrolase, hereinafter also referred to as hydrolase (C), preferably chosen from lipases, hereinafter also referred to as lipases (C) Includes.

[0048] "Lipase", "lipolytic enzyme", "lipid esterase" all refer to enzymes in EC class 3.1.1 ("carboxylester hydrolase"). Such lipases (C) can have lipase activity (or lipolytic activity; triacylglycerol lipase, EC 3.1.1.3), cutinase activity (EC 3.1.1.74; enzymes with cutinase activity may be referred to herein as cutinases), sterol esterase activity (EC 3.1.1.13) and / or wax-ester hydrolase activity (EC 3.1.1.50). Lipases (C) include those of bacterial or fungal origin.

[0049] Commercially available lipases (C) include, but are not limited to, those sold under the trade names Lipolase™, Lipex™, Lipolex™ and Lipoclean™ (Novozymes A / S), Preferenz™ L (DuPont), Lumafast (originally from Genencor) and Lipomax (Gist-Brocades / now DSM).

[0050] Suitable lipases (C) also include variants of the above lipases having lipolytic activity. Suitable lipase variants include variants having at least 40-100% identity when compared to the full-length polypeptide sequence of the parent enzyme described above. In one embodiment, the lipase variant having lipolytic activity may be at least 40%, at least 45%, at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% identity when compared to the full-length polypeptide sequence of the parent enzyme described above.

[0051] Lipase (C) has "lipolytic activity". Methods for determining lipolytic activity are well known in the literature (see, for example, Gupta et al. (2003), Biotechnol. Appl. Biochem. 37:63-71). For example, lipase activity can be measured by ester bond hydrolysis of the substrate paranitrophenyl palmitate (pNP-Palmitate, C:16), releasing the yellow colored pNP, detectable at 405 nm.

[0052] In one embodiment, the lipase (C) is selected from fungal triacylglycerol lipases (EC class 3.1.1.3). The fungal triacylglycerol lipase may be selected from Thermomyces lanuginosa lipases. In one embodiment, the at least one Thermomyces lanuginosa lipase is selected from the triacylglycerol lipase according to amino acids 1-269 of SEQ ID NO: 2 of US Pat. No. 5,869,438 and variants thereof having lipolytic activity.

[0053] The Thermomyces lanuginosa lipase can be selected from variants having lipolytic activity that is at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98% or at least 99% identical when compared to the full-length polypeptide sequence of amino acids 1-269 of SEQ ID NO:2 in U.S. Pat. No. 5,869,438.

[0054] The Thermomyces lanuginosa lipase can be selected from variants with lipolytic activity that contain only conservative mutations that do not belong to the functional domain of amino acids 1-269 of SEQ ID NO:2 of US 5,869,438. The lipase variants of this embodiment with lipolytic activity can be at least 95%, at least 96%, at least 97%, at least 98% or at least 99% similar when compared to the full length polypeptide sequence of amino acids 1-269 of SEQ ID NO:2 of US 5,869,438.

[0055] The Thermomyces lanuginosa lipase may be selected from variants having lipolytic activity comprising at least the following amino acid substitutions: T231R and N233R, when compared to amino acids 1-269 of SEQ ID NO:2 of US 5,869,438. The lipase variant may further comprise one or more of the following amino acid exchanges: Q4V, V60S, A150G, L227G, P256K, when compared to amino acids 1-269 of SEQ ID NO:2 of US 5,869,438.

[0056] The Thermomyces lanuginosa lipase may be selected from variants having lipolytic activity comprising at least the amino acid substitutions T231R, N233R, Q4V, V60S, A150G, L227G, P256K within the polypeptide sequence of amino acids 1-269 of SEQ ID NO:2 of U.S. Pat. No. 5,869,438, and which are at least 95%, at least 96% or at least 97% similar when compared to the full-length polypeptide sequence of amino acids 1-269 of SEQ ID NO:2 of U.S. Pat. No. 5,869,438.

[0057] The Thermomyces lanuginosa lipase can be selected from variants having lipolytic activity comprising the amino acid substitutions T231R and N233R within amino acids 1-269 of SEQ ID NO:2 of U.S. Pat. No. 5,869,438, and which are at least 95%, at least 96%, at least 97%, at least 98% or at least 99% similar when compared to the full length polypeptide sequence of amino acids 1-269 of SEQ ID NO:2 of U.S. Pat. No. 5,869,438.

[0058] The Thermomyces lanuginosa lipase may be a variant of amino acids 1-269 of SEQ ID NO:2 of US Patent No. 5,869,438 having lipolytic activity, characterized in that it contains the amino acid substitutions T231R and N233R. Said lipase may be referred to herein as Lipex.

[0059] In one embodiment of the present invention, a combination of at least two of the aforementioned lipases (C) can be used.

[0060] In one embodiment of the present invention, lipase (C) is included in the composition of the present invention in an amount such that the finished composition of the present invention has a lipolytic enzyme activity in the range of 100-0.005 LU / mg of the composition, preferably 25-0.05 LU / mg. A lipase unit (LU) is the amount of lipase that will produce 1 μmole of titratable fatty acid per minute in a pH stat under the following conditions: temperature 30°C; pH = 9.0; substrate is 13 mmol / L Ca 2+ and an emulsion of 3.3 wt % olive oil and 3.3% gum arabic in 5 mmol / L Tris buffer in the presence of 20 mmol / L NaCl.

[0061] In one embodiment of the present invention, the composition of the present invention comprises: (D) at least one protease (D), hereinafter also referred to as protease (D); Includes.

[0062] In one embodiment, the at least one protease (D) is selected from the group of serine endopeptidases (EC 3.4.21), most preferably from the group of subtilisin type proteases (EC 3.4.21.62). Serine proteases or serine peptidases are characterized by having a serine in the catalytic active site and form covalent adducts with substrates during catalysis. A serine protease in the context of the present invention may be selected from the group consisting of chymotrypsin (e.g., EC 3.4.21.1), elastase (e.g., EC 3.4.21.36), elastase (e.g., EC 3.4.21.37 or EC 3.4.21.71), granzyme (e.g., EC 3.4.21.78 or EC 3.4.21.79), kallikrein (e.g., EC 3.4.21.34, EC 3.4.21.35, EC 3.4.21.118, or EC 3.4.21.119), plasmin (e.g., EC 3.4.21.7), trypsin (e.g., EC 3.4.21.4), thrombin (e.g., EC 3.4.21.5), and subtilisin. Subtilisins are also known as subtilopeptidases, e.g., EC 3.4.21.62, the latter of which will hereinafter also be referred to as "subtilisins". The subtilisin-related class of serine proteases share a common amino acid sequence that defines a catalytic triad that distinguishes them from the chymotrypsin-related class of serine proteases. Both subtilisins and chymotrypsin-related serine proteases have a catalytic triad that includes an aspartate, a histidine, and a serine.

[0063] A protease is an active protein that exerts "protease activity" or "proteolytic activity." Proteolytic activity is related to the rate of degradation of a protein by a protease or proteolytic enzyme in a given period of time.

[0064] Methods for assaying proteolytic activity are well known in the literature (see, for example, Gupta et al. (2002), Appl. Microbiol. Biotechnol. 60:381-395). Proteolytic activity can be determined using Succinyl-Ala-Ala-Pro-Phe-p-nitroanilide (Suc-AAPF-pNA, abbreviated AAPF) as substrate: see, for example, DelMar et al. (1979), Analytical Biochem 99, 316-320). pNA is cleaved from the substrate molecule by proteolytic cleavage, resulting in the release of yellow free pNA, which is expressed as an OD 405 It can be quantified by measuring

[0065] Proteolytic activity can be provided in units per gram of enzyme. For example, 1 U of protease can correspond to the amount of protease that liberates 1 μmole of Folin-positive amino acids and peptides (as tyrosine) per minute at pH 8.0 and 37° C. (casein as substrate).

[0066] Subtilisin type proteases (EC 3.4.21.62) are proteases from the genera Bacillus, Clostridium, Enterococcus, Geobacillus, Lactobacillus, Lactococcus, Oceanobacillus, Staphylococcus, Streptococcus or Streptomyces. The protease may be a bacterial protease derived from a microorganism selected from the group consisting of Campylobacter, E. coli, Flavobacterium, Fusobacterium, Helicobacter, Ilyobacter, Neisseria, Pseudomonas, Salmonella, and Ureaplasma.

[0067] In one embodiment of the invention, the at least one protease (D) is selected from the group consisting of Bacillus alcalophilus, Bacillus amyloliquefaciens, Bacillus brevis, Bacillus circulans, Bacillus clausii, Bacillus coagulans, Bacillus firmus, Bacillus gibsonii, Bacillus lautus, Bacillus lentus, Bacillus licheniformis, Bacillus megaterium, Bacillus The protease is selected from Bacillus megaterium, Bacillus pumilus, Bacillus sphaericus, Bacillus stearothermophilus, Bacillus subtilis or Bacillus thuringiensis.

[0068] In one embodiment of the invention, the at least one protease (D) is selected from the following: subtilisin from Bacillus amyloliquefaciens BPN' (described by Vasantha et al. (1984) J. Bacteriol. Volume 159, p. 811-819 and J. A. Wells et al. (1983) in Nucleic Acids Research, Volume 11, p. 7911-7925); subtilisin from Bacillus licheniformis (subtilisin Carlsberg; E. L. Smith et al. (1968) in J. Biol Chem, Volume 243, pp. 2184-2191 and Jacobs et al. (1985) in Nucl. Acids Res, Vol. 13, p. 8913-8926); subtilisin PB92 (the original sequence of alkaline protease PB92 is described in EP 283075 A2); subtilisin 147 and / or 309 (Esperase®, Savinase®, respectively) disclosed in WO 89 / 06279; subtilisins from Bacillus lentus disclosed in WO 91 / 02792, such as subtilisin from Bacillus lentus DSM 5483 or variants of Bacillus lentus DSM 5483 described in WO 95 / 23221; Bacillus alcalophilus disclosed in DE 10064983; subtilisin from Bacillus gibsonii (DSM 14391) disclosed in WO 2003 / 054184; subtilisin from Bacillus sp.) (DSM 14390); a subtilisin from Bacillus sp. (DSM 14392) disclosed in WO 2003 / 055974; a subtilisin from Bacillus gibsonii (DSM 14393) disclosed in WO 2003 / 054184; a subtilisin having SEQ ID NO: 4 as described in WO 2005 / 063974; a subtilisin having SEQ ID NO: 4 as described in WO 2005 / 103244; a subtilisin having SEQ ID NO: 7 as described in WO 2005 / 103244; and a subtilisin having SEQ ID NO: 2 as described in German Patent No. 102005028295.4.

[0069] Examples of proteases useful according to the present invention include: variants described in WO 92 / 19729, WO 95 / 23221, WO 96 / 34946, WO 98 / 20115, WO 98 / 20116, WO 99 / 11768, WO 01 / 44452, WO 02 / 088340, WO 03 / 006602, WO 2004 / 03186, WO 2004 / 041979, WO 2007 / 006305, WO 2011 / 036263, WO 2011 / 036264 and WO 2011 / 072099. Suitable examples include the polypeptide of SEQ ID NO: 22 (Bacillus lentus) as described in EP 1 921 147 B1 (Bacillus lentus L.) having amino acid substitutions at one or more of the following positions: 3, 4, 9, 15, 24, 27, 33, 36, 57, 68, 76, 77, 87, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 106, 118, 120, 123, 128, 129, 130, 131, 154, 160, 167, 170, 194, 195, 199, 205, 206, 217, 218, 222, 224, 232, 235, 236, 245, 248, 252 and 274 (according to the BPN numbering), which in particular have proteolytic activity. lentus) which is the sequence of the mature alkaline protease from DSM 5483. In one embodiment, such proteases are not mutated at positions Asp32, His64 and Ser221 (according to BPN numbering).

[0070] In one embodiment, at least one protease (D) has a sequence according to SEQ ID NO: 22 as described in EP 1921147, or a protease that is at least 80% identical and has proteolytic activity. In one embodiment, said protease is characterized by having the amino acid glutamic acid, or aspartic acid, or glutamine, or alanine, or glycine, or serine at position 101 (according to BPN numbering) and has proteolytic activity. In one embodiment, the protease comprises one or more further substitutions: (a) a threonine (3T) at position 3; (b) an isoleucine (4I) at position 4; (c) an alanine, threonine or arginine (63A, 63T or 63R) at position 63; (d) an aspartic acid or glutamic acid (156D or 156E) at position 156; (e) a proline (194P) at position 194; (f) a methionine (199M) at position 199; (g) an isoleucine (205I) at position 205; (h) an aspartic acid, glutamic acid or glycine (217D, 217E or 217G) at position 217; (i) a combination of two or more amino acids from (a)-(h).

[0071] At least one protease (D) may be at least 80% identical to SEQ ID NO: 22 described in EP 1921147 and is characterized by comprising one amino acid (according to (a) to (h)) or a combination according to (i) together with amino acids 101E, 101D, 101N, 101Q, 101A, 101G or 101S (according to BPN numbering). In one embodiment, said protease is characterized by comprising the mutations (according to BPN numbering) R101E, or S3T+V4I+V205I, or R101E and S3T, V4I and V205I, or S3T+V4I+V199M+V205I+L217D and having proteolytic activity. The protease having the sequence according to SEQ ID NO: 22 with 101E described in EP 1 921 147 is sometimes referred to herein as Lavergy.

[0072] In one embodiment, the protease according to SEQ ID NO: 22 described in EP 1 921 147 is characterized by comprising the mutations (according to BPN numbering) S3T+V4I+S9R+A15T+V68A+D99S+R101S+A103S+I104V+N218D and having proteolytic activity.

[0073] The compositions of the present invention may comprise a combination of at least two proteases, preferably selected from the group of serine endopeptidases (EC 3.4.21), more preferably selected from the group of subtilisin-type proteases (EC 3.4.21.62), all of which have been previously disclosed.

[0074] It is preferred to use a combination of lipase (C) and protease (D) in the composition, for example 1-2% by weight of protease (D) and 0.1-0.5% by weight of lipase (C), both relative to the total weight of the composition.

[0075] In the context of the present invention, lipase (C) and / or protease (D) are considered stable if their enzymatic activity "available at the time of application" is at least equal to 60% compared to the initial enzymatic activity before storage. An enzyme may be called stable within the scope of the present invention if its enzymatic activity available at the time of application is at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or at least 99.5% compared to the initial enzymatic activity before storage.

[0076] Subtracting a% from 100% gives the "loss of enzyme activity during storage" compared to the initial enzyme activity before storage. In one embodiment, an enzyme is stable according to the present invention when essentially no loss of enzyme activity occurs during storage, i.e. the loss of enzyme activity is equal to 0% compared to the initial enzyme activity before storage. Within the present invention, virtually no loss of enzyme activity can mean that the loss of enzyme activity is less than 30%, less than 25%, less than 20%, less than 15%, less than 10%, less than 9%, less than 8%, less than 7%, less than 6%, less than 5%.

[0077] The compositions of the present invention may contain ingredients other than those previously mentioned, examples being non-ionic surfactants, fragrances, dyes, biocides, preservatives, enzymes, hydrotropes, builders, viscosity modifiers, polymers, buffers, defoamers, and anti-corrosion additives.

[0078] Preferred compositions of the present invention may contain one or more non-ionic surfactants.

[0079] Preferred nonionic surfactants are alkoxylated alcohols, di- and multiblock copolymers of ethylene oxide and propylene oxide, and reaction products of sorbitan with ethylene oxide or propylene oxide, alkyl polyglycosides (APGs), hydroxyalkyl mixed ethers, and amine oxides.

[0080] Preferred examples of alkoxylated alcohols and alkoxylated fatty alcohols are, for example, those represented by the general formula (IVa): [ka] [The variables in the formula are defined as follows: R 5 are the same or different and are hydrogen and linear C1-C 10 alkyl, preferably identical in each case ethyl, particularly preferably hydrogen or methyl, R 3 is C8~C 22-Alkyl, branched or linear, e.g. n-CH 17 , nC 10 H 21 , nC 12 H 25 , nC 14 H 29 , nC 16 H 33 or nC 18 H 37 is selected from R 4 is C1~C 10 - alkyl, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, sec-pentyl, neopentyl, 1,2-dimethylpropyl, isoamyl, n-hexyl, isohexyl, sec-hexyl, n-heptyl, n-octyl, 2-ethylhexyl, n-nonyl, n-decyl or isodecyl; R 5 are the same or different and are hydrogen and linear C1-C 10 alkyl, preferably identical in each case and ethyl, particularly preferably hydrogen or methyl. It is a compound of the formula:

[0081] The variables e and f range from 0 to 300, with the sum of e and f being at least 1, and preferably ranging from 3 to 50. It is preferred that e is in the range of 1 to 100 and f is in the range of 0 to 30.

[0082] In one embodiment, the compound of general formula (II) may be a block copolymer or a random copolymer, with block copolymers being preferred.

[0083] Other preferred examples of alkoxylated alcohols include those represented by the general formula (IVb): [ka] [The variables in the formula are defined as follows: R 5are identical or different and selected from hydrogen and linear C1-C0 alkyl, preferably are identical in each case and are ethyl, particularly preferably are hydrogen or methyl, R 6 is C6~C 20 -Alkyl, branched or linear, especially n-CH 17 , nC 10 H 21 , nC 12 H 25 , nC 13 H 27 , nC 15 H 31 , nC 14 H 29 , nC 16 H 33 , nC 18 H 37 is selected from a is a number ranging from 0 to 10, preferably from 1 to 6; b is a number ranging from 1 to 80, preferably from 4 to 20; d is a number ranging from 0 to 50, preferably from 4 to 25. It is a compound of the formula:

[0084] The sum of a+b+d is preferably in the range of 5-100, and even more preferably in the range of 9-50.

[0085] The compounds of general formulae (IVa) and (IVb) may be block or random copolymers, with block copolymers being preferred.

[0086] Further suitable non-ionic surfactants are selected from di- and multiblock copolymers composed of ethylene oxide and propylene oxide. Further suitable non-ionic surfactants are selected from ethoxylated or propoxylated sorbitan esters. Amine oxides or alkyl polyglycosides, especially linear C4-C 16 -Alkyl polyglucosides and branched C8-C 14 Likewise suitable are -alkyl polyglycosides, for example compounds of the average general formula (IVc). [ka] [In the formula, R 7 is -(CH2)2-R 8 and R 8 is C1-C4 alkyl, in particular ethyl, n-propyl or isopropyl; G 1 is selected from monosaccharides having 4 to 6 carbon atoms, in particular glucose and xylose, y3 ranges from 1.1 to 4, and y3 is the average number].

[0087] Further examples of non-ionic surfactants include those represented by the general formulae (V) and (VI): [ka] [AO is selected from ethylene oxide, propylene oxide and butylene oxide; EO is ethylene oxide, CH2CH2-O; R 9 is a branched or linear C8-C 18 -alkyl; R 6 is defined as above] It is a compound of the formula:

[0088] A 3 O is selected from propylene oxide and butylene oxide; w is a number ranging from 15 to 70, preferably from 30 to 50; w1 and w3 are numbers ranging from 1 to 5; and w2 is a number in the range of 13 to 35.

[0089] Surveys of suitable further nonionic surfactants are given in EP-A-0851023 and DE-A-19819187.

[0090] Mixtures of two or more different nonionic surfactants selected from the aforementioned nonionic surfactants may also be present.

[0091] Other surfactants which may be present may be selected from amphoteric (zwitterionic) surfactants and anionic surfactants, and mixtures thereof.

[0092] An example of an amphoteric surfactant is a surfactant that has positive and negative charges in the same molecule under the conditions of use.A preferred example of an amphoteric surfactant is the so-called betaine surfactant.Many examples of betaine surfactants have one quaternary nitrogen atom and one carboxylic acid group per molecule.A particularly preferred example of an amphoteric surfactant is cocamidopropyl betaine (lauramidopropyl betaine).

[0093] Examples of amine oxide surfactants include those represented by the general formula (VII): R 10 R 11 R 12 N → O (VII) [In the formula, R 10 , R 11 and R 12 are each independently an aliphatic, alicyclic or C2-C4 alkylene C 10 ~C 20 -alkylamide moieties. Preferably, R 12 is C8~C 20 -Alkyl or C2-C4-alkylene C 10 ~C 20 -alkylamide, and R 10 and R 11 are both methyl. It is a compound of the formula:

[0094] A particularly preferred example is lauryl dimethylamine oxide, also known as lauramine oxide. A more particularly preferred example is cocamidyl propyl dimethylamine oxide, also known as cocamidopropylamine oxide.

[0095] In one embodiment of the present invention, the composition of the present invention may contain 0.1 to 60% by weight of at least one surfactant selected from nonionic surfactants, amphoteric surfactants, and amine oxide surfactants.

[0096] In a preferred embodiment, the solid detergent composition of the present invention for cleaners, especially for automatic dishwashers, does not contain any anionic surfactants.

[0097] The composition of the present invention may contain at least one bleaching agent, also called bleach. The bleaching agent may be selected from chlorine bleaches and peroxide bleaches, and the peroxide bleaches may be selected from inorganic peroxide bleaches and organic peroxide bleaches. Inorganic peroxide bleaches selected from alkali metal percarbonates, alkali metal perborates and alkali metal persulfates are preferred.

[0098] Examples of organic peroxide bleaching agents are organic percarboxylic acids, especially organic percarboxylic acids.

[0099] In the compositions of the invention, the alkali metal percarbonates, especially sodium percarbonate, are preferably used in the form of a coating. Such coatings can be organic or inorganic. Examples include glycerol, sodium sulfate, silicates, sodium carbonate, and combinations of at least two of the above, such as sodium carbonate and sodium sulfate.

[0100] Suitable chlorine-containing bleaching agents are, for example, 1,3-dichloro-5,5-dimethylhydantoin, N-chlorosulfamide, chloramine T, chloramine B, sodium hypochlorite, calcium hypochlorite, magnesium hypochlorite, potassium hypochlorite, potassium dichloroisocyanurate and sodium dichloroisocyanurate.

[0101] The composition of the present invention may contain a chlorine-containing bleaching agent, for example in the range of 3 to 10% by weight.

[0102] The composition of the present invention may comprise one or more bleach catalysts. The bleach catalyst may be selected from bleach-boosting transition metal salts or transition metal complexes, such as manganese-, iron-, cobalt-, ruthenium- or molybdenum-salen complexes or carbonyl complexes. In addition to the complexes of manganese, iron, cobalt, ruthenium, molybdenum, titanium, vanadium and copper with nitrogen-containing tripod ligands, cobalt-, iron-, copper- and ruthenium-amine complexes may also be used as bleach catalysts.

[0103] The compositions of the present invention may also include one or more bleach activators, such as N-methylmorpholinium-acetonitrile salts ("MMA salts"), trimethylammonium acetonitrile salts, N-acylimides such as N-nonanoylsuccinimide, 1,5-diacetyl-2,2-dioxohexahydro-1,3,5-triazine ("DADHT"), or nitrile quats (trimethylammonium acetonitrile salts).

[0104] Further examples of suitable bleach activators are tetraacetylethylenediamine (TAED) and tetraacetylhexylenediamine.

[0105] Examples of fragrances are benzyl salicylate, 2-(4-tert-butylphenyl) 2-methylpropional, commercially available as Lilial®, and hexyl cinnamaldehyde.

[0106] Examples of dyes are Acid Blue 9, Acid Yellow 3, Acid Yellow 23, Acid Yellow 73, Pigment Yellow 101, Acid Green 1, Solvent Green 7, and Acid Green 25.

[0107] The composition of the present invention may contain one or more preservatives or biocides. Biocides and preservatives prevent deterioration of the liquid detergent composition of the present invention due to attack from microorganisms. Examples of biocides and preservatives are BTA (1,2,3-benzotriazole), benzalkonium chloride, 1,2-benzisothiazolin-3-one ("BIT"), 2-methyl-2H-isothiazol-3-one ("MIT") and 5-chloro-2-methyl-2H-isothiazol-3-one ("CIT"), benzoic acid, sorbic acid, iodopropynyl butylcarbamate ("IPBC"), dichlorodimethylhydantoin ("DCDMH"), bromochlorodimethylhydantoin ("BCDMH") and dibromodimethylhydantoin ("DBDMH").

[0108] Particularly interesting examples are the following antimicrobial and / or antiseptic agents: 4,4'-Dichloro-2-hydroxydiphenyl ether (CAS number 3380-30-1), further name: 5-chloro-2-(4-chlorophenoxy)phenol (Diclosan, DCPP), commercially available as a 30% by weight solution of 4,4'-dichloro-2-hydroxydiphenyl ether in 1,2-propylene glycol under the trade name Tinosan® HP 100: and 2-Phenoxyethanol (CAS number 122-99-6, further names: phenoxyethanol, methylphenyl-glycol, phenoxetol, ethylene glycol phenyl ether, ethylene glycol monophenyl ether, Protectol® PE); 2-Bromo-2-nitropropane-1,3-diol (CAS number 52-51-7, further names: 2-Bromo-2-nitro-1,3-propanediol, Bronopol®, Protectol® BN, Myacide AS); Glutaraldehyde (CAS number 111-30-8, further names: 1-5-pentanedial, pentane-1,5-dial, glutaral, glutaric dialdehyde, Protectol® GA, Protectol® GA 50, Myacide® GA); Glyoxal (CAS number 107-22-2; further names: ethanedial, oxylaldehyde, 1,2-ethanedial, Protectol® GL); 2-Butyl-benzo[d]isothiazol-3-one (BBIT, CAS number 4299-07-4); 2-Methyl-2H-isothiazol-3-one (MIT, CAS number 2682-20-4); 2-Octyl-2H-isothiazol-3-one (OIT, CAS number 26530-20-1); 5-Chloro-2-methyl-2H-isothiazol-3-one (CIT, CMIT, CAS number 26172-55-4); Mixture of 5-chloro-2-methyl-2H-isothiazol-3-one (CMIT, EINECS 247-500-7) and 2-Methyl-2H-isothiazol-3-one (MIT, EINECS 220-239-6) (CMIT / MIT mixture, CAS number 55965-84-9);1,2-Benzisothiazol-3(2H)-one (BIT, CAS number 2634-33-5); Hexa-2,4-dienoic acid (sorbic acid, CAS number 110-44-1) and its salts, such as: calcium sorbate, sodium sorbate, potassium (E,E)-hexa-2,4-dienoic acid (potassium sorbate), CAS number 24634-61-5); Lactic acid and its salts; especially sodium lactate; L-(+)-lactic acid (CAS number 79-33-4); Benzoic acid (CAS No. 65-85-0, CAS No. 532-32-1) as well as salts of benzoic acid, such as sodium benzoate, ammonium benzoate, calcium benzoate, magnesium benzoate, MEA-benzoate, potassium benzoate; Salicylic acid and its salts, such as calcium salicylate, magnesium salicylate, MEA salicylate, sodium salicylate, potassium salicylate, TEA salicylate; benzalkonium chloride, benzalkonium bromide, benzalkonium saccharinate (CAS numbers 8001-54-5, 63449-41-2, 91080-29-4, 68989-01-5, 68424-85-1, 68391-01-5, 61789-y71-7, 85409-22-9); Didecyldimethylammonium chloride (DDAC, CAS number 68424-95-3 and CAS number 7173-51-5); N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine (diamine, CAS number 2372-82-9); Peracetic acid (CAS number 79-21-0); Hydrogen peroxide (CAS number 7722-84-1). The biocides or preservatives may be added to the compositions of the invention in a concentration of 0.001 to 10% relative to the total weight of the composition. Preferably, the compositions of the invention contain 2-phenoxyethanol in a concentration of 0.1 to 2% or 4,4'-dichloro-2-hydroxydiphenyl ether (DCPP) in a concentration of 0.005 to 0.6%.

[0109] The present invention therefore further relates to a method for protecting the compositions of the invention from bacterial contamination or growth, the method comprising the addition of 2-phenoxyethanol.

[0110] The present invention therefore relates to a method for imparting antimicrobial efficacy to fabrics after treatment with a composition of the invention containing 4,4'-dichloro 2-hydroxydiphenyl ether (DCPP).

[0111] Examples of viscosity modifiers are agar, carrageenan, tragacanth, gum arabic, alginates, pectin, hydroxyethyl cellulose, hydroxypropyl cellulose, starch, gelatin, locust bean gum, crosslinked poly(meth)acrlyates, such as polyacrylic acid crosslinked with bis(meth)acrylamide, as well as silicic acid, clays (including but not limited to montmorillonite, zeolite, dextrin, and casein).

[0112] A hydrotrope in the context of the present invention is a compound that promotes the dissolution of compounds that have limited solubility in water. Examples of hydrotropes are, but are not limited to, organic solvents such as ethanol, isopropanol, ethylene glycol, 1,2-propylene glycol, and further organic solvents that are miscible with water under normal conditions. Further examples of suitable hydrotropes are the sodium salts of toluenesulfonic acid, xylenesulfonic acid, and cumenesulfonic acid.

[0113] Examples of polymers other than the polymer (A) are especially polyacrylic acids and the respective alkali metal salts thereof, especially the sodium salts thereof. Suitable polymers are especially polyacrylic acids, preferably having average molecular weights M in the range from 2,000 to 40,000 g / mol, preferably from 2,000 to 10,000 g / mol, in particular from 3,000 to 8,000 g / mol. w Each is partially or completely neutralized with an alkali, especially sodium. Likewise suitable copolymeric polycarboxylates are, in particular, copolymers of acrylic acid and methacrylic acid, and copolymers of acrylic acid or methacrylic acid with maleic acid and / or fumaric acid. Polyacrylic acid and its respective alkali metal salts can function as soil redeposition inhibitors.

[0114] A further example of a polymer is polyvinylpyrrolidone (PVP), which can function as a dye transfer inhibitor.

[0115] Further examples of polymers are polyethylene terephthalate, polyoxyethylene terephthalate, and polyethylene terephthalate endcapped with one or two hydrophilic groups per molecule, the hydrophilic groups being selected from CH2CH2CH2-SONa, CH2CH(CH2-SONa)2, and CH2CH(CH2SONa)CH2-SONa.

[0116] Examples of buffers are monoethanolamine and N,N,N-triethanolamine.

[0117] An example of a defoamer is silicone.

[0118] The composition of the present invention is not only good for cleaning soiled laundry against organic fat stains such as oil.The liquid detergent composition of the present invention is very useful for removing non-bleachable stains such as, but not limited to, stains from red wine, tea, coffee, various fruit juices such as vegetable and berry juice from laundry.In addition, the composition of the present invention does not leave any residue on woven fabrics.

[0119] A further aspect of the present invention is therefore the use of the compositions of the present invention for laundry care, laundry care in this context including laundry cleaning.

[0120] In another aspect, the compositions of the present invention are useful for cleaning hard surfaces. A further aspect of the present invention is therefore the use of the compositions of the present invention in cleaning hard surfaces.

[0121] In the context of the present invention, the term "hard surface cleaning compositions" includes cleaners for home care and industrial or institutional applications. The term "hard surface cleaning compositions" includes compositions for dishwashing, especially hand dishwashing and automatic dishwashing and ceramic cleaning, as well as compositions for bathroom cleaning, kitchen cleaning, floor cleaning, plumbing descaling, window cleaning, automobile cleaning including truck cleaning, as well as open plant cleaning, yard cleaning, metal cleaning, germicidal cleaning, farm cleaning, high pressure cleaning, but does not include laundry detergent compositions. A particular embodiment of the hard surface cleaning composition is an automatic dishwashing composition.

[0122] In the context of the present invention, the terms "hard surface cleaning composition" and "hard surface cleaner composition" are used interchangeably.

[0123] In the context of the present invention, unless otherwise specified, percentages for ingredients of laundry detergent compositions are percent by weight and refer to the total solids of the respective laundry detergent composition. In the context of the present invention, unless otherwise specified, percentages for ingredients of detergent compositions for hard surface cleaners are percent by weight and refer to the total solids of detergent compositions for hard surface cleaning.

[0124] The compositions of the present invention when used in automatic dishwashing preferably comprise (E) at least one builder component selected from aminopolycarboxylic acids and preferably their alkali metal salts, also called complexing agent (E) or sequestering agent (E) in the context of the present invention; In the context of the present invention, the terms "sequestering agent" and "chelating agent" are used interchangeably.

[0125] Examples of the sequestering agent (E) include alkali metal salts of MGDA (methylglycine diacetate), alkali metal salts of GLDA (glutamic acid diacetate), alkali metal salts of IDS (iminodisuccinic acid), alkali metal salts of EDTA, and alkali metal salts of iminodisuccinic acid having 20 to 90 mol % of N atoms in at least one CH2COO -Polymers having complexing groups, such as polyethyleneimine, and their respective alkali metal salts, in particular their sodium salts, for example MGDA-Na3, GLDA-Na4, or IDS-Na4.

[0126] Preferred sequestering agents are those of the general formula (IXa) [CH3-CH(COO)-N(CH2-COO)2]M 3-x2 H x2 (IXa) [wherein M is the same or different and is selected from ammonium and alkali metal cations, such as sodium cations, potassium cations, and combinations of at least two of the foregoing. Ammonium may be substituted with alkyl, but is not limited to unsubstituted ammonium NH4 + Preferred examples of alkali metal cations are sodium and potassium and combinations of sodium and potassium, and even more preferred in the compounds according to general formula (IIa) are all M's the same and they are all Na; In formula (IIa), x2 is in the range of 0 to 1.0. or (IXb) [OOC-CH2CH2-CH(COO)-N(CH2-COO)2]M 4-x3 H x3 (IXb) [In the formula, M is as defined above, and x3 in formula (IXb) is in the range of 0 to 2.0, preferably up to 1.0] or (IXc) [OOC-CH2-CH(COO)]-N-CH(COO)-CH2-COO]M 4-x4 H x4 (IXc) [In the formula, M is as defined above, and x4 in formula (IXc) is in the range of 0 to 2.0, preferably up to 1.0] This is due to.

[0127] In one embodiment of the invention, the composition of the invention comprises a combination of at least two of the foregoing, for example a combination of a chelating agent according to general formula (IXa) and a chelating agent according to general formula (IXb).

[0128] The chelating agents according to the general formulae (IXa) and (IXb) are preferred. The chelating agents according to the general formula (IXa) are even more preferred.

[0129] In one embodiment of the present invention, the compound according to general formula (IXa) is selected from the ammonium or alkali metal salts of racemic MGDA and the ammonium and alkali metal salts of a mixture of L- and D-enantiomers according to formula (IXa), said mixture containing predominantly the respective L-isomer with an enantiomeric excess (ee) in the range of 5-99%, preferably 5-95%, more preferably 10-75% and even more preferably 10-66%.

[0130] In one embodiment of the invention, the compound according to general formula (IXb) is selected from at least one alkali metal salt of a mixture of the L-enantiomer and the D-enantiomer according to formula (IXb), said mixture preferably containing a racemic mixture or containing predominantly the respective L-isomer, for example with an enantiomeric excess (ee) in the range of 5-99%, preferably 15-95%.

[0131] The enantiomeric excess of the compound according to general formula (IXa) can be determined by measuring polarized light (polarimetry) or preferably by chromatography, for example by HPLC with a chiral column, for example using one or more cyclodextrins as stationary phase or using a chiral stationary phase of the ligand exchange (Pirkle-brush) concept. Determination of the ee (enantiomeric excess) by HPLC is preferred, using immobilized optically active amines such as D-penicillamine in the presence of copper(+II) salts. The enantiomeric excess of the compound according to general formula (IXb) can be determined by measuring polarized light (polarimetry).

[0132] Due to environmental concerns related to the use of phosphates, advantageous compositions are preferably phosphate-free. "Phosphate-free" in the context of the present invention should be understood to mean a phosphate and polyphosphate content ranging from the gravimetrically determined detection level to 1% by weight in total, preferably ranging from 10 ppm to 0.2% by weight.

[0133] In one embodiment of the present invention, the composition of the present invention contains a sequestering agent (E) in an amount of 0.5 to 50% by weight, preferably 1 to 35% by weight, based on the total solid content.

[0134] To be suitable as a liquid laundry composition, the compositions of the present invention may be in bulk form or in unit dose form, such as in the form of a sachet or pouch. Suitable materials for pouches are water-soluble polymers such as polyvinyl alcohol.

[0135] In a preferred embodiment of the invention, the composition of the invention is in liquid or gel form at ambient temperature. In another preferred embodiment of the invention, the composition of the invention is in solid form, such as a powder or tablet, at ambient temperature.

[0136] In one embodiment of the invention, the composition of the invention is in liquid or gel form and has a pH value in the range of 7 to 9, preferably 7.5 to 8.5. In an embodiment in which the composition of the invention is a solid, its pH value may be in the range of 7.5 to 11, measured after dissolving 1 g / 100 ml in distilled water at ambient temperature. In an embodiment in which the composition of the invention is used on hard surfaces such as tiles, e.g. bathroom tiles, it is also possible that its pH value is acidic, e.g. 3 to 6.

[0137] In one embodiment of the present invention, the composition of the present invention is in liquid or gel form and has a total solids content in the range of 8 to 80%, preferably 10 to 50%, measured after drying under vacuum at 80°C.

[0138] Another aspect of the present invention relates to polymer (A), hereinafter also referred to as inventive polymer (A) or simply as polymer (A). Inventive polymer (A) has already been described.

[0139] In one aspect, the present invention relates to a method for improving the cleaning performance of a liquid detergent composition by adding a polymer (A) according to the present invention to said detergent composition, preferably comprising at least one lipase and / or at least one protease.

[0140] The term "improved cleaning performance" as used herein can indicate that the polymer (A) provides better, i.e. improved, properties in removing soils under relevant cleaning conditions, when compared to the cleaning performance of a detergent composition that does not contain the polymer (A). In one embodiment, "improved cleaning performance" means that the cleaning performance of a detergent comprising a polymer (A) and at least one enzyme, preferably at least one hydrolase (C), in particular at least one lipase (C) and / or at least one protease (D), is improved when compared to the cleaning performance of a detergent comprising a polymer (A) and no enzyme. In one embodiment, "improved cleaning performance" means that the cleaning performance of a detergent comprising a polymer (A) and an enzyme, preferably a hydrolase (C), more preferably a lipase (C) and / or a protease (D), is improved when compared to the cleaning performance of a detergent comprising at least one enzyme, preferably at least one hydrolase (C), preferably a lipase (C) and / or at least one protease (D), and no polymer (A).

[0141] The term "suitable washing conditions" in this specification refers to the conditions actually used in a washing machine, automatic dishwasher or manual washing process, in particular the washing temperature, time, washing equipment, foam concentration, detergent type and water hardness.

[0142] Further disclosed is a process for producing polymer (A), the process comprising: (α) at ​​least one molecule having a primary amino group, (β) at least one compound selected from alkoxylated diols or polyols esterified with at least two equivalents of (meth)acrylate per molecule, and bis(meth)acrylamides; or (γ) with either a C1-C3-alkyl (meth)acrylate (γ1), such as methyl (meth)acrylate, or ethyl (meth)acrylate, or isopropyl (meth)acrylate, followed by addition of an aliphatic diol or triol (γ2), and optionally (δ) Unsealed or C1~C 10 -Alkyl-terminated or aliphatic C2-C 20 -Alkyl fatty acid or C 10 ~C 20 at least one mono(meth)acrylate of polyethylene glycol esterified with an alkenyl fatty acid; (ε) or optionally of the formula H-NR 2a R 2b The method includes reacting the amine with

[0143] Said processes will be described in more detail below: Reactants (α), (β), (γ) and - if applicable - (δ) or (ε) will be referred to as compound (α), compound (β), compound (γ1), compound (γ2), compound (δ) or compound (ε), respectively, or simply as (α), (β), (γ1), (γ2) and, if applicable, (δ) or (ε).

[0144] First, at least one compound (α) having a primary amino group, -NH2, is selected, preferably exactly one compound (α). Such compound (α) has exactly one primary amino group per molecule. Compound (α) may have functional groups other than the primary amino group, such as a tertiary amino group or a hydroxyl group, but does not contain a secondary amino group.

[0145] Compound (α) can have at least one tertiary amine group per molecule.

[0146] In a preferred embodiment, such a compound (α) has the formula R 1 -NH2. 1 is selected from C2-C4-alkyl, such as ethyl, isopropyl, n-propyl, n-butyl, isobutyl, sec-butyl or tert-butyl, each of which is unsubstituted or is selected from hydroxy or -NR 2a R 2b (where R 2a and R 2b are the same or different and are selected from C1-C4-alkyl, preferably methyl or ethyl, or NR 2a R 2b together form a C5-C6-cycloalkyleneamino or 1-imidazole group. C1-C4-alkyl is as defined above or NR 2a R 2b together form a C5-C6-cycloalkyleneamino group. -NR 2a R 2b Preferred examples of the group include -N(CH3)2, -N(C2H5)2, -N(CH2)4, and -N(CH2)5.

[0147] Examples of suitable compounds (α) are ethylamine, 2-ethanolamine, 2-(N,N-dimethylamino)-ethylamine, 2-(N,N-diethylamino)ethylamine, isopropylamine, n-propylamine, 3-aminopropyl-1-imidazole, 3-(N,N-dimethylamino)propylamine, 3-(N,N-diethylamino)propylamine, butylamine, tert-butylamine, 2-methoxyethylamine, 3-methoxypropylamine, and 2-amino-1-butanol. Preferred compounds (α) are 2-(N,N-dimethylamino)ethylamine, 2-(N,N-diethylamino)ethylamine, and isopropylamine.

[0148] Compound (β) is selected from bisacrylamides, such as methylene bis(meth)acrylamide, methylene bismethacrylamide, ethylene bisacrylamide, N,N'-(1,2-dihydroxyethylene)bisacrylamide, piperazine bisacrylamide, N,N'-hexamethylene bis(methacrylamide), poly(ethylene glycol) diacrylamide, and alkoxylated diols or polyols esterified with at least two equivalents of (meth)acrylate per molecule. Examples of diols are aliphatic C2-C6-diols, preferably C2-C4-diols, such as ethylene glycol, 1,2-propylene glycol, 1,3-propylene diol, 1,4-butylene diol, etc.

[0149] Aliphatic C2-C4-diols such as ethylene glycol and 1,2-propylene glycol are preferred.

[0150] In the context of the present invention, the term "alkoxylation" includes polyalkoxylation, with the term "poly" referring to two or more alkoxylate groups per diol or polyol. Preferred polyalkoxylations are selected from polyethoxylations and polypropoxylations, and combinations thereof, preferably with more moles of EO than moles of PO. In an even more preferred embodiment, the alkoxylated diol is (AO) y1 wherein AO is selected from ethylene oxide ("EO"), propylene oxide ("PO"), and combinations thereof, and y1 is 2 to 200, preferably 2 to 10.

[0151] (AO) y1 In the embodiment where refers to a combination of EO and PO, such EO and PO may be arranged randomly or, preferably, blockwise, in two or three blocks. (AO) y1 In a preferred embodiment in which AO refers to a combination of EO and PO, at least 50 mol %, for example 50 to 90 mol %, more preferably 65 to 90 mol % of AO is EO.

[0152] (AO) y1 It is even more preferred that all AO in are EO.

[0153] Examples of compounds (β) are diethylene glycol bis(meth)acrylate, dipropylene glycol bis(meth)acrylate and polyethylene glycol bis(meth)acrylate having an average molecular weight Mw in the range of 230 to 2,500 g / mol, preferably 250 to 1250 g / mol.

[0154] In each case the acrylates are preferred over the respective methacrylates.

[0155] The amount is preferably selected such that the molar amount of (α) is within the range of 0.9:1 to 2:1 molar equivalents relative to the (meth)acrylate groups of (β), preferably 0.9:1 to 1.1:1 molar equivalents, most preferably 1.0:1.0 molar equivalents. It should be understood that in each molecule of compound (α), two protons are available for reaction.

[0156] The reaction of compound (α) with compound (β) can be carried out in a single solvent or in a combination of several solvents. Suitable solvents include alcohols such as methanol, ethanol, isopropanol, n-butanol, di-n-butyl ether, and ethers such as THF and 1,4-dioxane, as well as mixtures of any solvent selected from alcohols such as methanol, ethanol, isopropanol, n-butanol, and ethers such as THF and 1,4-dioxane with water to the extent that the solvents are miscible with water at the reaction temperature. In another embodiment, the process of the present invention is carried out in bulk.

[0157] The reaction of compound (α) with compound (β) may be carried out at a temperature in the range of 50 to 150° C., preferably 60 to 120° C. In embodiments in which a solvent is used, the boiling point of the solvent is the upper temperature limit.

[0158] The reaction of compound (α) with compound (β) may have a period ranging from 1 hour to 24 hours, preferably from 2 to 6 hours.

[0159] The reaction of compound (α) with compound (β) can be carried out at a pH value ranging from 8 to 11 to avoid protonation of the amino group of compound (α). The pH value can be controlled by adding a strong base, such as, but not limited to, NaOH or KOH, and can be determined by taking a sample from the reaction mixture. The sample is then diluted with water in a 1:1 weight ratio. The pH value of the sample is measured at 23° C., and the pH of the reaction mixture is adjusted by adding a strong base.

[0160] In another embodiment, compound (α) is reacted, preferably sequentially, with a combination of compound (γ1) and compound (γ2).

[0161] The C1-C3-alkyl (meth)acrylate (γ1) is selected from methyl (meth)acrylate, ethyl (meth)acrylate, n-propyl (meth)acrylate, and isopropyl (meth)acrylate, with the acrylate being preferred in each case over the respective methacrylate, with ethyl acrylate and isopropyl acrylate being more preferred.

[0162] The amount is preferably selected such that the molar amount of (α) relative to the (meth)acrylate groups of (γ1) is in the range of 1:1.8 to 1:2.2, preferably 1:1.9 to 1:2.1, and even more preferably as close as possible to 1:2. It should be understood that in each molecule of compound (α), two protons are available for reaction.

[0163] The reaction of compound (α) with compound (γ1) can be carried out in a single solvent or in a combination of several solvents. Suitable solvents include alcohols such as methanol, ethanol, isopropanol, n-butanol, di-n-butyl ether, and ethers such as THF and 1,4-dioxane, as well as mixtures of any solvent selected from alcohols such as methanol, ethanol, isopropanol, n-butanol, and ethers such as THF and 1,4-dioxane with water to the extent that the solvents are miscible with water at the reaction temperature. In another embodiment, the process of the present invention is carried out in bulk.

[0164] The reaction of compound (α) with compound (γ1) may be carried out at a temperature in the range of 50 to 150° C., preferably 60 to 90° C. In an embodiment in which a solvent is used, the boiling point of the solvent is the upper temperature limit.

[0165] The reaction of compound (α) with compound (γ1) may have a period ranging from 1 hour to 12 hours, preferably from 2 to 6 hours.

[0166] Preferably, the reaction of compound (α) with compound (γ1) is carried out at a pH value in the range of 8-11 to avoid protonation of the amino group of compound (α). The pH value can be controlled by adding a strong base, such as but not limited to NaOH or KOH, and can be determined by taking a sample from the reaction mixture. The sample is then diluted with water in a 1:1 weight ratio. The pH value of the sample is measured at 23° C. and the pH of the reaction mixture is adjusted by adding a strong base.

[0167] An intermediate is obtained. Such intermediate may be purified, but preferably the solvent, if present, is simply removed and the intermediate is reacted with compound (γ2). This step may be considered as a transesterification.

[0168] Compound (γ2) is selected from diols or polyols that can be alkoxylated. Examples of diols are aliphatic C2-C6-diols, preferably C2-C4-diols, such as ethylene glycol, 1,2-propylene glycol, 1,3-propylene diol, 1,4-butylene diol, 2,3-butane diol, and isosorbide.

[0169] Aliphatic C2-C4-diols such as ethylene glycol and 1,2-propylene glycol are preferred.

[0170] In the context of the present invention, the term "alkoxylation" includes polyalkoxylation, with the term "poly" referring to two or more alkoxylate groups per diol or polyol. Preferred polyalkoxylations are selected from polyethoxylations and polypropoxylations, and combinations thereof, preferably with more moles of EO than moles of PO. In an even more preferred embodiment, the alkoxylated diol is (AO) y1 -H, where AO is selected from ethylene oxide ("EO"), propylene oxide ("PO"), and combinations thereof, and y1 is 2 to 200, preferably 2 to 10.

[0171] (AO) y1 In the embodiment where H refers to a combination of EO and PO, such EO and PO may be arranged randomly or, preferably, blockwise, in two or three blocks. (AO) y1 In a preferred embodiment in which AO refers to a combination of EO and PO, at least 50 mol %, for example 50 to 90 mol %, more preferably 65 to 90 mol % of AO is EO.

[0172] Even more preferably, (AO) y1 All AO in -H are EO.

[0173] Examples of the compound (γ2) are ethylene glycol, propylene glycol, diethylene glycol, dipropylene glycol, and glycols having an average molecular weight M in the range of 320 to 2,500 g / mol, preferably 600 to 1,200 g / mol. n It is a polyethylene glycol having the formula:

[0174] The amount is preferably chosen such that the molar ratio of C1-C3-alkyl ester groups of the intermediate to the hydroxyl groups of (γ2) is in the range of 1.2:1 to 1:1.5, preferably 1:1 to 1:1.1.

[0175] The reaction of the intermediate with compound (γ2) can be carried out in a single solvent or in a combination of several solvents. Suitable solvents are alcohols such as methanol, ethanol, isopropanol, n-butanol, di-n-butyl ether and ethers such as THF and 1,4-dioxane. Water is not a suitable solvent. In a preferred embodiment, the transesterification is carried out in bulk.

[0176] The reaction of the intermediate with compound (γ2) may be carried out at a temperature in the range of 50 to 220° C., preferably 60 to 90° C. In embodiments in which a solvent is used, the boiling point of the solvent is the upper temperature limit.

[0177] The reaction of the intermediate with compound (γ2) may have a period ranging from 6 hours to 48 hours, preferably from 10 to 24 hours.

[0178] The reaction of the intermediate with compound (γ2) can be carried out in the absence of a catalyst. However, it is preferred to use a catalyst. Examples are methanesulfuric acid, para-toluenesulfonic acid, NaOCH3, scandium triflate (trifluoroacetate), 1,5,7-triazabicyclo[4,4,0]dec-5-ene, titanoctanoate, and Ti(OBu)4.

[0179] In the reaction of the intermediate with compound (γ2), the respective C1-C3-alcohol is formed as a by-product, which is preferably removed, for example by use of a Dean-Stark apparatus or simply by distillation, for example under reduced pressure.

[0180] A polymer (A) is obtained which can be purified or otherwise post-treated, for example by removing the solvents used during the synthesis or by inactivating the catalysts used, for example by neutralization.

[0181] Optionally, at least one compound (δ) or at least one compound (ε) may be reacted with the polymer (A).

[0182] The compound (δ) is an unsealed or C1-C 10 -Alkyl group, preferably methyl-capped or aliphatic C2-C 20 -Alkyl fatty acid or C 10 ~C 20 - mono(meth)acrylates of polyethylene glycols esterified with alkenyl fatty acids.

[0183] C2~C 20 Examples of -alkyl fatty acids are capric acid, lauric acid, myristic acid, palmitic acid, stearic acid, or arachidic acid; or C 10 ~C 20 Examples of alkenyl fatty acids are eg oleic acid, palmitoleic acid, linoleic acid, linoelaidic acid and α-linolenic acid, preferably oleic acid, lauric acid, palmitic acid and stearic acid.

[0184] Conversion with compound (δ) is useful if polymer (A) still has unreacted amino groups, e.g., 1-2 unreacted primary or secondary amine groups per polymer chain. In embodiments where excess compound (α) is used, unreacted amino groups may remain.

[0185] Compound (ε) has the formula H-NR2a R 2b (where R 2a and R 2b are the same or different and are selected from C1-C4-alkyl, preferably methyl or ethyl, or NR 2a R 2b are C5-C6-cycloalkyleneamino or amines of the formula (which together form a 1-imidazole group). C1-C4-alkyl is as defined above or NR 2a R 2b together form a C5-C6-cycloalkyleneamino group. H-NR 2a R 2b Preferred examples include HN(CH3)2, HN(C2H5)2, HN(CH2)4, and HN(CH2)5.

[0186] The conversion with compound (ε) is useful if polymer (A) still has unreacted (meth)acrylate groups, for example 1-2 unreacted (meth)acrylates per polymer chain. In embodiments using the shortcut with compound (α), unreacted (meth)acrylate groups may remain.

[0187] The reaction conditions for the conversion with compound (δ) or (ε) are similar to the reaction conditions for the reaction of compound (α) with compound (β). EXAMPLES

[0188] The present invention is further illustrated by examples.

[0189] Summary: D6-DMSO as solvent 1 H-NMR spectra were recorded. The conversion of the acrylate was determined by determining the ratio of the olefinic protons to the protons from the tertiary carbon atom of the propylene glycol moiety.

[0190] The K values ​​were measured in 1 wt % aqueous solutions. Gel permeation chromatography (GPC) was performed in hexafluoroisopropanol containing 0.05 wt % trifluoroacetic acid.

[0191] I. Synthesis of Polymer (A) I.1 Synthesis of polymer (A.1) A four-necked round bottom flask equipped with a stirrer and a dropping funnel was charged with 454.26 g of dipropylene glycol diacrylate solution (β.1) (80%, 1.5 mol, impurity: dipropylene glycol) dissolved in 350 g of isopropanol. A mixture of 350 g of water and 153.27 g of 3-(dimethylamino)-1-propylamine (α.1) (102 g / mol, 1.5 mol) was slowly added and stirred at 50° C. for 4 hours, then cooled to ambient temperature. 1 In H-NMR, it was observed that the intensity of the acrylate peaks decreased to 9%, indicating a conversion of 91% of the acrylate groups. Polymer (A.1) was obtained. K value (1 wt.% in water): 15.5, GPC: Mn=8190 g / mol, Mw=13800 g / mol, Mw / Mn=1.7, Hazen color index (ISO 6271:2015): 62.

[0192] I.2 Synthesis of polymer (A.2) A four-necked round bottom flask equipped with a stirrer and a dropping funnel was charged with 40 g of dipropylene glycol diacrylate solution (β.1) (80%, 0.20 mol) in 40 g of isopropanol. A mixture of 40 g of water and 12.2 g of ethanolamine (α.2) (0.2 mol) was slowly added to the reaction mixture and stirred at 50° C. for 6 hours, then cooled to ambient temperature. 1 In H-NMR, it was observed that the intensity of the acrylate peaks had decreased to 15%, indicating a conversion of the acrylate groups of 85%. Polymer (A.2) was obtained. K value (water): 14.0, GPC: M n = 5520 g / mol, M w = 13900 g / mol, M w / M n =2.5.

[0193] I.3 Synthesis of polymer (A.3) A four-necked round-bottom flask equipped with a stirrer and a dropping funnel was charged with 100.95 g of dipropylene glycol diacrylate solution (β.1) (80%, 0.3337 mol) dissolved in 70 g of isopropanol. A mixture of 70 g of water, 3-(dimethylamino)-1-propylamine (α.1) (1.67 mol) and 20.86 g of 1-(3-aminopropyl)imidazole (α.2) (0.1670 mol) was slowly added. The pH value was adjusted to about 9 with NaOH. The obtained reaction mixture was stirred at 90° C. for 5 hours and then cooled to ambient temperature. Polymer (A.3) was obtained. 1 A conversion of 95% of the acrylate groups was observed in H-NMR. K value (water): 13.9, GPC: Mn = 3970 g / mol, Mw = 13700 g / mol, (Mw / Mn) = 3.5, Hazen color number (ISO 6271:2015): 100.

[0194] 1.4 Synthesis of polymer (A.4) A four-necked round-bottom flask equipped with a stirrer and a dropping funnel was charged with a solution of 300.36 g of ethyl acrylate (γ1.1) (3.0 mol) dissolved in 350 g of isopropanol. A mixture of 350 g of water and 153.27 g of 3-(dimethylamino)-1-propylamine (α.1) (1.503 mol) was slowly added and stirred at 50° C. for 4 hours, then cooled to ambient temperature. 1 In the H-NMR spectrum, a conversion of 95% of the acrylate groups was observed. The solvent was removed under reduced pressure. An intermediate was obtained. 151.21 g of the intermediate was placed in a 500 mL three-necked round-bottom flask equipped with a stirrer, thermometer and distillation bridge. Then, 38 g of 1,3-propanediol (γ2.1) (0.5 mol) and sodium methylate (30% in methanol) were added and the mixture was stirred at 100° C. for 7 hours. Ethanol was distilled off during the reaction. Polymer (A.4) was obtained. K value (water): 15.2, GPC: M n = 3380 g / mol, M w = 5000 g / mol, D(M w / M n )=1.5.

[0195] II. Cleaning performance II.1 Laundry Cleaning The primary wash performance of the inventive polymers was tested in a washing machine in which the wash solution was prepared using water with 14° dH hardness (2.5 mmol / L; Ca:Mg:HCO3 4:1:8) containing 3.0 g / L of liquid test detergent L.1 (see composition in Table 2.1 or 2.2) and 2.0% of polymer (A).

[0196] [Table 1]

[0197] [Table 2]

[0198] (D.1): [ka]

[0199] The polymer (A) was added to a washing liquor (addition amount of 3% based on the weight of the liquid model detergent (owod)) containing either the polymer-free liquid model composition L.1 or L.2, respectively, together with commercially soiled fabrics (P-H108: clayey soil, P-H115: standard clay; P-H144: red china clay; P-H145: tennis court clay, from the Center of Test Materials CFT Vlaardingen) and 5 g of a commercially available soil ballast sheet wfk SBL2004 (by wfk Testgewebe GmbH Brueggen). The washing conditions were 3 g / L detergent, 250 mL liquor, 30 min, 40° C., 4 measurements. After washing, the fabrics were rinsed and dried. The fabrics were instrumentally evaluated before and after washing using a ColourConsult MACH5 multi area color measurement device showing laboratory measurements. From these laboratory measurements, the ΔE values ​​between unwashed and washed stains were calculated. The higher the ΔE value, the better the performance. To better judge the pure cleaning effect of each polymer sample itself, the obtained values ​​were further expressed as ΔΔE values ​​relative to a reference without polymer (baseline correction to plain cleaning effect of detergent only). Again, the higher the ΔΔE values ​​observed, the better the performance.

[0200] The overall degree of cleaning was evaluated using color measurements. The reflectance values ​​of the stains on the standard soiled cloth were measured using a sphere reflectance spectrometer (SF 500 model from Datacolor, USA, wavelength range 360-700 nm, optical geometry d / 8°) equipped with a 460 nm UV cutoff filter. Here, using the classification of color space by CIE-Lab, the lightness L*, a* value on the red-green axis, and b* value on the yellow-green axis were measured before and after cleaning, and the average values ​​were calculated for each stain on the standard soiled cloth. The change in color value (delta E, ΔE) is defined by the following formula and is automatically calculated by the evaluation color tool.

number

[0201] [Table 3]

[0202] [Table 4]

[0203] III. Biodegradation Tests Summary: The test was performed according to the OECD 301F Guidelines. According to the OECD 301F Guidelines, the test is valid if: 1. The reference material reaches 60% within 14 days. 2. The difference in the extreme values ​​of test reproducibility by the end of the test is less than 20%. 3. The oxygen uptake of the inoculum blank should be 20-30 mgO2 / l and should not exceed 60 mgO2 / l. 4. The pH value measured at the end of the test must be between 6 and 8.5.

[0204] Description of the test methods used in connection with the present invention: Biodegradation in wastewater was tested in triplicate using the manometric respirometry method of OECD 301F, an aerobic test that measures the biodegradation of wastewater samples by measuring the consumption of oxygen. Measured amounts of wastewater were spiked with 100 mg / L of the test substance, nominally the only carbon source, together with an inoculum (aerated sludge taken from the municipal wastewater treatment plant of Mannheim, Germany). The sludge was stirred in a closed flask at constant temperature (25°C) for 28 days. The consumption of oxygen is measured by measuring the change in pressure in a closed flask using an Oxi TopC. The released carbon dioxide is absorbed in a sodium hydroxide solution. A nitrification inhibitor was added to the flask to prevent the consumption of oxygen by nitrification. The amount of oxygen taken up by the microbial population during the biodegradation of the test substance (corrected for the uptake by a blank inoculum run in parallel) is expressed as a percentage of ThOD (theoretical oxygen demand measured by elemental analysis of the compound). A positive control, glucose / glutamic acid, is run as a reference substance along with the test samples in each cabinet. The results of the biodegradation tests are summarized in Table 4.

[0205] Calculations: Theoretical Oxygen Demand: The amount of O2 required to oxidize a compound to its final oxidation product. This amount is calculated using elemental analysis data. % Biodegradation: Experimental O2 uptake x 100 divided by theoretical oxygen demand.

[0206] [Table 5]

[0207] In each test, the reference material had a biodegradation greater than 60%.

Claims

1. 1. A composition comprising: (A) an average molecular weight M of at least 1,500 g / mol; w At least one polymer having the general formula (I) [Formula 1] [In the formula, Z 1 are the same or different and are selected from hydrogen and methyl; R 1 are the same or different, unsubstituted C 2 ~C 4 -alkyl or hydroxy or -NR 2a R 2b C replaced with 2 ~C 4 - alkyl, R 2a and R 2b are the same or different, C 1 ~C 4 -alkyl, or NR 2a R 2b is C 5 ~C 6 -cycloalkyleneamino or 1-imidazole groups, n is selected from 3 to 100; X 1 is O and N-R 3 (R 3 is selected from hydrogen and methyl; A 1 are the same or different, C 2 ~C 6 -Alkylene and (AO) y1 wherein AO is selected from ethylene oxide, propylene oxide, and combinations thereof, and y1 is selected from 2 to 200. At least one polymer containing as repeating units structural units according to (B) at least one anionic surfactant; A composition comprising:

2. The polymer (A) has the structural formula (II): [Case 2] [In the formula, A 2 (A.O.) y2 wherein AO is selected from ethylene oxide, propylene oxide, and combinations thereof, and y2 is from 2 to 200; Z 2 is hydrogen, C 1 ~C 10 -Alkyl, aliphatic C 2 ~C 20 -Carboxylates of alkyl fatty acids, or C 10 ~C 20 -carboxylates of alkenyl fatty acids, the asterisk indicating the moiety attached to the N atom of the polymer (A). Based on Or (III) [C3] [In the formula, the group (III) is X 1 is bonded to the polymer (A) via other variables are defined as above] The composition of claim 1 further comprising the group:

3. A 1 3. The composition according to claim 1, wherein all AO are selected from ethylene oxide.

4. The polymer (A) has an average molecular weight M in the range of 2,500 to 100,000 g / mol. w The composition according to any one of claims 1 to 3, comprising:

5. The composition further comprises (C) at least one hydrolase The composition according to any one of claims 1 to 4, comprising:

6. The composition according to claim 5, wherein the hydrolase (C) is a lipase (C) selected from triacylglycerol lipases (EC 3.1.1.3).

7. A method for protecting a composition according to any one of claims 1 to 6 from microbial contamination or growth, comprising the addition of 2-phenoxyethanol.

8. A method for imparting antimicrobial benefit to fabrics after treatment with a composition according to any one of claims 1 to 6 which contains 4,4'-dichloro 2-hydroxydiphenyl ether.

9. Use of a composition according to any one of claims 1 to 6 for laundry care or hand dishwashing detergents.

10. A method for improving the cleaning performance of a liquid detergent composition by adding a polymer (A) to a composition according to any one of claims 1 to 6, which further comprises at least one lipase and / or at least one protease.